Sodium-glucose co-transporter 2 (SGLT2) inhibitors: a growing class of anti-diabetic agents

Sodium-glucose co-transporter 2 (SGLT2) inhibitors: a growing class of anti-diabetic agents

Although several treatment options are available to reduce hyperglycemia, only about half of individuals with diagnosed diabetes mellitus (DM) achieve recommended glycemic targets. New agents that reduce blood glucose concentrations by novel mechanisms and have acceptable safety profiles are needed...

Full description

Bibliographic Details
Main Author: Eva M Vivian
Format: Article
Language:English
Published: BioExcel Publishing Ltd 2014-12-01
Series:Drugs in Context
Subjects:
oral; canagliflozin; dapagliflozin; diabetes mellitus
oral
oral administration
canagliflozin
dapagliflozin
diabetes mellitus type 2
antidiabetic agents
Online Access:http://www.drugsincontext.com/sodium-glucose-co-transporter-2-sglt2-inhibitors-growing-class-anti-diabetic-agents/

Internet

http://www.drugsincontext.com/sodium-glucose-co-transporter-2-sglt2-inhibitors-growing-class-anti-diabetic-agents/

Similar Items